(EL) Estee Lauder Companies - Ratings and Ratios
Skincare, Makeup, Fragrance, Haircare, Tools
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.90% |
| Yield on Cost 5y | 0.76% |
| Yield CAGR 5y | 11.83% |
| Payout Consistency | 95.0% |
| Payout Ratio | 83.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 43.7% |
| Value at Risk 5%th | 62.3% |
| Relative Tail Risk | -13.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.76 |
| Alpha | 21.36 |
| CAGR/Max DD | -0.32 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.359 |
| Beta | 1.338 |
| Beta Downside | 1.696 |
| Drawdowns 3y | |
|---|---|
| Max DD | 81.40% |
| Mean DD | 51.74% |
| Median DD | 57.49% |
Description: EL Estee Lauder Companies October 14, 2025
The Estée Lauder Companies Inc. (NYSE: EL) designs, manufactures, markets and sells a broad portfolio of prestige beauty products-including skin-care, makeup, fragrance and hair-care-through a multi-channel network of department stores, specialty retailers, e-commerce platforms, salons, spas and its own direct-to-consumer stores.
Its brand roster spans high-end labels such as La Mer, Jo Malone London, Tom Ford and Le Labo, alongside mass-prestige names like Clinique, M·A·C, The Ordinary and Aveda, giving the company exposure across price points and consumer segments.
Recent financials show EL generated $17.7 billion in net sales for FY 2023, with a 6 % year-over-year increase driven primarily by a 30 % jump in digital sales and strong growth in anti-aging skin-care. Adjusted EPS rose to $2.57 and gross margins held near 71 %, reflecting pricing power despite inflationary pressure on raw-material costs.
Key macro drivers include rising global demand for premium skin-care, especially in Asia-Pacific, and consumer willingness to pay a premium for sustainability-focused formulations-trends that have historically delivered a 4–5 % premium price premium for “green” product lines.
For a deeper quantitative breakdown of EL’s valuation metrics and scenario analysis, the ValueRay platform offers a useful toolkit.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-930.0m TTM) > 0 and > 6% of Revenue (6% = 866.5m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.29% (prev 11.19%; Δ 0.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.60b > Net Income -930.0m (YES >=105%, WARN >=100%) |
| Net Debt (7.20b) to EBITDA (451.0m) ratio: 15.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (363.3m) change vs 12m ago 1.03% (target <= -2.0% for YES) |
| Gross Margin 74.19% (prev 72.29%; Δ 1.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 71.06% (prev 72.48%; Δ -1.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.96 (EBITDA TTM 451.0m / Interest Expense TTM 398.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.09
| (A) 0.08 = (Total Current Assets 6.71b - Total Current Liabilities 5.08b) / Total Assets 19.33b |
| (B) 0.60 = Retained Earnings (Balance) 11.59b / Total Assets 19.33b |
| (C) -0.02 = EBIT TTM -381.0m / Avg Total Assets 20.32b |
| (D) 0.68 = Book Value of Equity 10.46b / Total Liabilities 15.44b |
| Total Rating: 3.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 26.17
| 1. Piotroski 2.50pt |
| 2. FCF Yield 2.56% |
| 3. FCF Margin 7.24% |
| 4. Debt/Equity 2.42 |
| 5. Debt/Ebitda 15.97 |
| 6. ROIC - WACC (= -10.09)% |
| 7. RoE -22.87% |
| 8. Rev. Trend -60.48% |
| 9. EPS Trend -50.08% |
What is the price of EL shares?
Over the past week, the price has changed by +4.41%, over one month by -8.48%, over three months by +4.08% and over the past year by +28.35%.
Is EL a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 23
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the EL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 101.9 | 10.8% |
| Analysts Target Price | 101.9 | 10.8% |
| ValueRay Target Price | 79.9 | -13.1% |
EL Fundamental Data Overview November 26, 2025
P/E Forward = 45.4545
P/S = 2.3296
P/B = 8.3281
P/EG = 1.7946
Beta = 1.174
Revenue TTM = 14.44b USD
EBIT TTM = -381.0m USD
EBITDA TTM = 451.0m USD
Long Term Debt = 7.32b USD (from longTermDebt, last quarter)
Short Term Debt = 418.0m USD (from shortTermDebt, last quarter)
Debt = 9.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.20b USD (from netDebt column, last quarter)
Enterprise Value = 40.86b USD (33.65b + Debt 9.42b - CCE 2.22b)
Interest Coverage Ratio = -0.96 (Ebit TTM -381.0m / Interest Expense TTM 398.0m)
FCF Yield = 2.56% (FCF TTM 1.04b / Enterprise Value 40.86b)
FCF Margin = 7.24% (FCF TTM 1.04b / Revenue TTM 14.44b)
Net Margin = -6.44% (Net Income TTM -930.0m / Revenue TTM 14.44b)
Gross Margin = 74.19% ((Revenue TTM 14.44b - Cost of Revenue TTM 3.73b) / Revenue TTM)
Gross Margin QoQ = 73.37% (prev 71.97%)
Tobins Q-Ratio = 2.11 (Enterprise Value 40.86b / Total Assets 19.33b)
Interest Expense / Debt = 0.91% (Interest Expense 86.0m / Debt 9.42b)
Taxrate = 56.88% (62.0m / 109.0m)
NOPAT = -164.3m (EBIT -381.0m * (1 - 56.88%)) [loss with tax shield]
Current Ratio = 1.32 (Total Current Assets 6.71b / Total Current Liabilities 5.08b)
Debt / Equity = 2.42 (Debt 9.42b / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = 15.97 (Net Debt 7.20b / EBITDA 451.0m)
Debt / FCF = 6.89 (Net Debt 7.20b / FCF TTM 1.04b)
Total Stockholder Equity = 4.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.81% (Net Income -930.0m / Total Assets 19.33b)
RoE = -22.87% (Net Income TTM -930.0m / Total Stockholder Equity 4.07b)
RoCE = -3.35% (EBIT -381.0m / Capital Employed (Equity 4.07b + L.T.Debt 7.32b))
RoIC = -1.44% (negative operating profit) (NOPAT -164.3m / Invested Capital 11.37b)
WACC = 8.64% (E(33.65b)/V(43.08b) * Re(10.95%) + D(9.42b)/V(43.08b) * Rd(0.91%) * (1-Tc(0.57)))
Discount Rate = 10.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.46%
[DCF Debug] Terminal Value 58.59% ; FCFE base≈1.16b ; Y1≈761.7m ; Y5≈348.3m
Fair Price DCF = 18.64 (DCF Value 4.58b / Shares Outstanding 245.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -50.08 | EPS CAGR: -44.99% | SUE: 0.54 | # QB: 0
Revenue Correlation: -60.48 | Revenue CAGR: -11.65% | SUE: 0.05 | # QB: 0
Additional Sources for EL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle